middle.news

Next Science Wins Derivative Complaint Dismissal, Battles Continue with Former Employees

3:24am on Monday 2nd of June, 2025 AEST Healthcare
Read Story

Next Science Wins Derivative Complaint Dismissal, Battles Continue with Former Employees

3:24am on Monday 2nd of June, 2025 AEST
Key Points
  • Derivative complaint by Michael Morello dismissed for lack of standing
  • Ongoing litigation against former employees for breach of post-employment restraints
  • Next Science focuses on proprietary XBIO™ technology targeting biofilm infections
  • Company holds full ownership and patent protection of XBIO™ technology
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Next Science (ASX:NXS)
OPEN ARTICLE